OBJECTIVE: To investigate the validity and reliability of the EuroQol-5D (EQ-5D), the 12-item Short-Form Health Survey (SF-12v2), and the Hospital Anxiety and Depression Scale (HADS) in a stable coronary population. STUDY DESIGN: Cross-sectional study EUROASPIRE III. SETTING: Quality of life data (QoL) were available on 8745 patients hospitalized for coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), acute myocardial infarction (AMI), or myocardial ischemia. They were interviewed and examined at least 6 months after their hospital admission. Reliability and validity of the 3 instruments were tested. Internal consistency, and discriminative, convergent, criterion and construct validity were assessed. RESULTS: Cronbach's alpha indicated good internal consistency for all measures (0.73 to 0.87). Discriminative validity analyses confirmed significant QoL differences between known groups: age, gender, educational level. In addition, all hypothesized correlations between QoL constructs (convergent validity) and items (criterion validity) were confirmed with significant correlations. Confirmatory factor analyses indicated good construct validity for HADS and SF-12v2. On country-specific level, results were roughly similar. CONCLUSION: The EQ-5D as well as the SF-12v2 and the HADS are reliable and valid instruments for use in a stable coronary population, both on aggregate European level and on country-specific level. However, our results must be generalized with caution, because EUROASPIRE III patients might not be representative for all patients with stable coronary heart disease.
OBJECTIVE: To investigate the validity and reliability of the EuroQol-5D (EQ-5D), the 12-item Short-Form Health Survey (SF-12v2), and the Hospital Anxiety and Depression Scale (HADS) in a stable coronary population. STUDY DESIGN: Cross-sectional study EUROASPIRE III. SETTING: Quality of life data (QoL) were available on 8745 patients hospitalized for coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), acute myocardial infarction (AMI), or myocardial ischemia. They were interviewed and examined at least 6 months after their hospital admission. Reliability and validity of the 3 instruments were tested. Internal consistency, and discriminative, convergent, criterion and construct validity were assessed. RESULTS: Cronbach's alpha indicated good internal consistency for all measures (0.73 to 0.87). Discriminative validity analyses confirmed significant QoL differences between known groups: age, gender, educational level. In addition, all hypothesized correlations between QoL constructs (convergent validity) and items (criterion validity) were confirmed with significant correlations. Confirmatory factor analyses indicated good construct validity for HADS and SF-12v2. On country-specific level, results were roughly similar. CONCLUSION: The EQ-5D as well as the SF-12v2 and the HADS are reliable and valid instruments for use in a stable coronary population, both on aggregate European level and on country-specific level. However, our results must be generalized with caution, because EUROASPIRE III patients might not be representative for all patients with stable coronary heart disease.
Authors: Evelyn Kunschitz; Oliver Friedrich; Christine Schöppl; Thomas W Weiss; Wolfgang Miehsler; Johann Sipötz; Gabriele Moser Journal: Wien Klin Wochenschr Date: 2016-08-05 Impact factor: 1.704
Authors: Delphine De Smedt; Els Clays; Lieven Annemans; Sofie Pardaens; Kornelia Kotseva; Dirk De Bacquer Journal: Int J Public Health Date: 2014-04-26 Impact factor: 3.380
Authors: Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek Journal: Qual Life Res Date: 2016-07-29 Impact factor: 4.147
Authors: Julia Köbe; Katharina Hucklenbroich; Nils Geisendörfer; Markus Bettin; Gerrit Frommeyer; Florian Reinke; Dirk Dechering; Markus Burgmer; Lars Eckardt Journal: Clin Res Cardiol Date: 2016-11-22 Impact factor: 5.460
Authors: Stephan Seklehner; Paul Friedrich Engelhardt; Mesut Remzi; Harun Fajkovic; Zana Saratlija-Novakovic; Matthias Skopek; Irene Resch; Mario Duvnjak; Stephan Hruby; Clemens Wehrberger; Davor Librenjak; Wilhelm Hübner; Eckart Breinl; Claus Riedl Journal: Qual Life Res Date: 2016-03-17 Impact factor: 4.147
Authors: Selina Kikkenborg Berg; Jette Svanholm; Astrid Lauberg; Britt Borregaard; Margrethe Herning; Anna Mygind; Anne Vinggaard Christensen; Anne Illemann Christensen; Ola Ekholm; Knud Juel; Lars Thrysøe Journal: BMJ Open Date: 2014-05-02 Impact factor: 2.692
Authors: Johann Sipötz; Oliver Friedrich; Stefan Höfer; Werner Benzer; Thomas Chatsakos; Georg Gaul Journal: Health Qual Life Outcomes Date: 2013-08-27 Impact factor: 3.186